2019
DOI: 10.1016/j.immuni.2018.12.016
|View full text |Cite
|
Sign up to set email alerts
|

A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells

Abstract: Graphical Abstract Highlights d IPEX mutation M370I leads to unrestrained Th2 immune response d M370I mutation generates Th2-like Treg cells expressing GATA3 and Th2 cytokines d M370I mutation induces de novo Foxp3 binding sites in the Th2 locus d M370I Treg cells have increased chromatin interaction at the Th2 locus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
52
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 86 publications
(58 citation statements)
references
References 56 publications
6
52
0
Order By: Relevance
“…Some FOXP3 mutations cause less severe diseases. For example, patients with a point mutation in the domain swap interface of FOXP3 protein develop a Th2-related disease [202]. In addition to Foxp3 mutations, deficiency in other regulators of Treg-suppressive functions, such as TRAF3 [203], CD28 [204], Id2/Id3 [205], Ubc13 [206], Ndfip1 [207], NF-κB p65 [208], Helios [209], Th-POK/LRF [210], EZH2 [211], BACH2 [212,213], SATB1 [214], IRF-4 and Blimp-1 [215], and LKB1 [216], can also result in severe autoimmune diseases, although most of these studies were carried out in mice, and their relevance in human diseases remains to be tested.…”
Section: Treg Related Diseasesmentioning
confidence: 99%
“…Some FOXP3 mutations cause less severe diseases. For example, patients with a point mutation in the domain swap interface of FOXP3 protein develop a Th2-related disease [202]. In addition to Foxp3 mutations, deficiency in other regulators of Treg-suppressive functions, such as TRAF3 [203], CD28 [204], Id2/Id3 [205], Ubc13 [206], Ndfip1 [207], NF-κB p65 [208], Helios [209], Th-POK/LRF [210], EZH2 [211], BACH2 [212,213], SATB1 [214], IRF-4 and Blimp-1 [215], and LKB1 [216], can also result in severe autoimmune diseases, although most of these studies were carried out in mice, and their relevance in human diseases remains to be tested.…”
Section: Treg Related Diseasesmentioning
confidence: 99%
“…They have also been shown to be resistant to immunosuppressive treatment with dexamethasone in asthmatic patients in contrast to classic Th2 cells . Defects in the key transcription factor FoxP3 in murine Treg cells result in the reduction of Treg cell regulatory functions and induce a Th2‐like phenotype, highlighting the plasticity among T‐cell lineages . Despite extensive evidence for the reciprocal molecular regulation of Th1 and Th2 cells, hybrid IL‐4 and IFN‐γ positive T cells exist that resist reprogramming into either classic Th1 or Th2 cells in humans and mice .…”
Section: Blurring Borders Among Th1 Th2 and Th17 Traitsmentioning
confidence: 99%
“…These cells also dampen host antitumor immunity, decreasing the efficacy of tumor immune surveillance (3). The key transcription factor Foxp3 has a critical role in the differentiation and function of Tregs (4,5), and knockdown or mutations of Foxp3 attenuate the immunosuppressive capacity of Tregs (6,7). Similarly, depletion of Foxp3 + CD4 + Tregs results in severe autoimmunity in otherwise normal animals and can be reversed by reconstituting Tregs (8,9).…”
Section: Introductionmentioning
confidence: 99%